Stem Cells and Artificial Intelligence: Ethical and Legal Challenges in Healthcare

Add to Calendar Stem Cells and Artificial Intelligence: Ethical and Legal Challenges in Healthcare 11/2/2019 9:00:00 AM 11/2/2019 5:15:00 PM Asia/Riyadh For More Details: https://wcmq.cloud-cme.com/course/courseoverview?EID=1851 Description: A court in the United States recently held that a stem cell clinic had misbranded stem cell products in violation of US law. This has arisen at a time when clinics are attempting to cash in on the demand for such treatment despite the lack of scientific evidence. At the same time, the march of artificial intelligence systems to diagnose and treat patients continues apace, relying on big pools of patient ... Lecture Hall 4, WCM-Q false MM/DD/YYYY

Date & Location

Saturday, November 2, 2019, 9:00 AM - 5:15 PM, Lecture Hall 4, WCM-Q

Overview

A court in the United States recently held that a stem cell clinic had misbranded stem cell products in violation of US law. This has arisen at a time when clinics are attempting to cash in on the demand for such treatment despite the lack of scientific evidence. At the same time, the march of artificial intelligence systems to diagnose and treat patients continues apace, relying on big pools of patient data. Robots are used to undertake medical tasks but the algorithms dictating their work is written by humans. At this moment in time, the law reacts to events but does not pre-empt the ethical and legal dilemmas that arise. A race continues between scientists whose natural course is scientific advancement, ethicists debating the appropriate moral boundaries, and the breathless lawyer attempting to develop regulations. Greater dialogue between these groups is vital to ensure that the science continues to develop, but that it does so in an ethically appropriate manner, covered by a legal framework that protects patients while encouraging scientific advancement.

Target Audience

Specialties - Academic/Research, Allied Health Professionals, Dentists, Educators, Nurses, Pharmacists, Physicians, Students

Overall Learning Objective

At the end of the activity, participants will be able to:

1- Discuss the pressing issues concerning stem cells and artificial intelligence and their impact on practice in Qatar and wider scientific community
2- Explore ethical challenges of stem cell clinical practice and patient care delivered in whole or in part by artificial intelligence systems
3- Explore the development of future legal frameworks governing the use of AI in the region as well as the appropriate protections for patients benefitting from stem cell treatments

Registration

100 QAR

Changes or Cancellations

Name changes or substitutions are not permitted.
All cancellation and refund requests must be made in writing and submitted via email to [email protected].
For a full refund of the registration fee, the cancellation request must be received at least 7 days prior to the session. No refund will be offered for cancellation request thereafter.
We will attempt to process the refund within 30 days of receiving any cancellation request.
Weill Cornell Medicine-Qatar reserves the right to cancel the course. In the event of a cancellation, fee deposit will be returned, but we will not be responsible for any other expenses including restricted or non-refundable airfare or hotel deposits.

Accreditation

DHP

Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Ministry of Public Health's Department of Healthcare Professions.

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 7.00 hour(s).

ACCME

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this Live Activity for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to the Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias.